F. Canis

917 total citations
10 papers, 94 citations indexed

About

F. Canis is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, F. Canis has authored 10 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Epidemiology and 3 papers in Molecular Medicine. Recurrent topics in F. Canis's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Streptococcal Infections and Treatments (2 papers). F. Canis is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Streptococcal Infections and Treatments (2 papers). F. Canis collaborates with scholars based in France, Mali and United States. F. Canis's co-authors include Dominique Turck, M.O. Husson, S. Ategbo, P. Vic, Andrea S. Vincent, René Courcol, Alban Le Monnier, B. Durand-Gasselin, Tatiana Galpérine and Philippe Vanhems and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Journal of Antimicrobial Chemotherapy and Health and Quality of Life Outcomes.

In The Last Decade

F. Canis

7 papers receiving 90 citations

Peers

F. Canis
F. Canis
Citations per year, relative to F. Canis F. Canis (= 1×) peers Irene Coloretti

Countries citing papers authored by F. Canis

Since Specialization
Citations

This map shows the geographic impact of F. Canis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Canis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Canis more than expected).

Fields of papers citing papers by F. Canis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Canis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Canis. The network helps show where F. Canis may publish in the future.

Co-authorship network of co-authors of F. Canis

This figure shows the co-authorship network connecting the top 25 collaborators of F. Canis. A scholar is included among the top collaborators of F. Canis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Canis. F. Canis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ettahar, N., et al.. (2025). Lab efficiency and improvements in the management of bloodstream infections: a before and after study. European Journal of Clinical Microbiology & Infectious Diseases. 44(10). 2465–2474.
2.
Barbut, Frédéric, Tatiana Galpérine, Philippe Vanhems, et al.. (2019). Quality of life and utility decrement associated with Clostridium difficile infection in a French hospital setting. Health and Quality of Life Outcomes. 17(1). 6–6. 34 indexed citations
3.
Subtil, D., G. Brabant, Julia Salleron, et al.. (2013). 3: Early clindamycin for bacterial vaginosis in low-risk pregnancy: the PREMEVA1 randomized, multicenter, double-blind, placebo-controlled trial. American Journal of Obstetrics and Gynecology. 210(1). S3–S3. 7 indexed citations
4.
Canis, F., et al.. (2012). La vaginose bactérienne est-elle facteur de risque de prématurité ? Étude d’une cohorte de 1336 patientes au centre hospitalier d’Arras. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 41(3). 262–270. 2 indexed citations
5.
6.
Canis, F., D Trivier, P. Vic, et al.. (1998). [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].. PubMed. 46(6). 449–51. 5 indexed citations
7.
Canis, F., M.O. Husson, Dominique Turck, et al.. (1997). Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients. Journal of Antimicrobial Chemotherapy. 39(3). 431–433. 30 indexed citations
8.
Canis, F., J.-D. Cavallo, & M. Husson. (1997). [Evaluation of bactericidal activity of cefpirome-aminoglycoside combination against Pseudomonas aeruginosa strains with intermediate sensitivity to cefpirome and in various phenotypes of beta-lactam resistance].. PubMed. 45(5). 420–3. 1 indexed citations
9.
Zandecki, Marc, Thierry Façon, Claude Preudhomme, et al.. (1994). Significance of Circulating Plasma Cells in Multiple Myeloma. Leukemia & lymphoma. 14(5-6). 491–496. 9 indexed citations
10.
Canis, F., et al.. (1994). Septicémie avec infection du liquide d'ascite à Corynebacterium diphtheriae. Médecine et Maladies Infectieuses. 24(8-9). 852–854.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026